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Objective. To describe the prevalence of patients who screen positive for bipolar disorder (BD) symptoms in primary care comparing
two screening instruments: Mood Disorders Questionnaire (MDQ) and Hypomania Checklist (HCL-32). Participants. Adult
patients presenting to their primary care practitioners for any cause and reporting current depression symptoms or a depressive
episode in the last 6 months.Methods. Subjects completed MDQ and HCL-32, and clinical diagnosis was assessed by a psychiatrist
following DSM-IV criteria. Depressive symptoms were evaluated in a subgroup with the Patient Health Questionnaire (PHQ-9).
Results. A total of 94 patients were approached to participate and 93 completed the survey. Among these, 8.9% screened positive
with MDQ and 43.0% with HCL-32. MDQ positive had more likely features associated with BD: panic disorder and smoking habit
(𝑃 < .05). The best test accuracy was performed by cut-off 5 for MDQ (sensitivity = .91; specificity = .67) and 15 for HCL-32
(sensitivity = .64; specificity = .57). Higher total score of PHQ-9 was related to higher total scores at the screening tests (𝑃 < .001).
Conclusion. There is a significant prevalence of bipolar symptoms in primary care depressed patients. MDQ seems to have better
accuracy and feasibility than HCL-32, features that fit well in the busy setting of primary care.
1. Introduction
Bipolar disorder (BD) has an estimated lifetime prevalence
rate between 2% and 6% when wider range of bipolar
spectrum disorders is considered [1]. It is a complex mood
disorder frequently associated with medical and psychiatric
comorbidity and high suicide rate [2]. Suicidal risk in BD
is esteemed to be 15–20 times higher than the general
population, and self-harm ideation is reported by 79% of
patients [3, 4]. Nevertheless, an average delay of 8–10 years
from first onset of mood symptoms to a formal diagnosis of
bipolar disorder occurs [5, 6]. Longitudinal researches show
that a patient is euthymic for half of the time, while manic
or hypomanic symptoms are present only in the 12%; in the
rest of the time, a patient has depressive symptoms [7, 8].
Hypomanic symptoms are often perceived as egosyntonic,
while it is depression that usually leads the patient to the
physician [9]. Thus, any loss or lack of information on
hypomanic symptoms increases the bias in favour of a
diagnosis of depression [10].
Primary care is the health service entry point for the
majority of people suffering from depressive disorders and
therefore could play a key role in the detection and manage-
ment of BD. Although prevalence of symptoms and diagnosis
of BD is elevated in depressed patients of primary care, Frye
et al. found that 78% of primary care physicians (PCPs) failed
to detect ormisdiagnosed BD [11, 12]. To improve recognition
of BD, several rapid instruments have been developed in
the last ten years, including the Mood Disorder Question-
naire (MDQ) and the Hypomania Checklist (HCL-32), now
probably the most studied [13, 14]. Both the instruments are
validated in psychiatric outpatients settings, and guidelines
suggest their usefulness in secondary care, while few studies
assessed the employ in primary care [15].
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Gorski et al. first used MDQ in primary care to test the
association with principal complaints of patients referring
to their PCP and found that participants who did complain
of anxiety and depression had higher incidence of positive
MDQ scores (16.4%) [16, 17]. Das et al. found a lower
prevalence (9.8%) in low-income patients and confirmed the
association with anxiety and depression, worse quality of life,
and more functional impairment [18]. Consistently, a French
study reported a similar value of prevalence (8.3%) and a
higher rate of positive screening among younger patients,
separated, divorced, and unemployed [19]. Other studies con-
ducted in specific populations, patients taking antidepressant,
the presence of current indices of BD (depression, anxiety,
and substance abuse) found higher prevalence rate ranging
from 21.3% and 27.9% [20–22]. Only one study used HCL-
32 in a primary care setting in comparison with another
screening instrument, the Bipolar Spectrum Disorders Scale,
reporting the 28.27% of test positivity with the HCL-32 [23,
24].
In addition, no studies directly compared the two instru-
ments MDQ and HCL-32 in the primary care setting, while
some comparisons are available in studies on psychiatric
outpatient services. All of them showed similar overall
screening qualities of the two tests, and sensitivity of HCL-
32 was always slightly higher [25–30].
The objective of our study was to assess the prevalence of
symptoms of the bipolar spectrum in primary care patients
with current depression using the Mood Disorder Question-
naire (MDQ) and the Hypomania Checklist (HCL-32). In
particular, we performed the first comparison between the
two instruments in primary care.
2. Method
2.1. Setting and Participants. The present study was con-
ducted in two primary care groups in Bologna in the first
semester of 2011, located in the Borgo Panigale and Porto dis-
tricts and included a total of 37 PCPs. In these groups, a psy-
chiatric consultation-liaison project was implemented since
2001 and 2006, respectively. Furthermore, PCPs received a
training about depressive disorder symptoms and DSM-IV
diagnosis and criteria in 2009.
PCPs were asked to refer all patients aged 18 or more they
visited in the study period and reported clinically relevant
depressive symptoms or suffered from a depressive episode.
Exclusion criteria were refusal to receive a psychiatric con-
sultation or to participate in the study, inability to read or
write, medical illness that would prevent completion of the
interview, previous diagnosis of bipolar disorder, psychotic
disorders, and mental retardation or cognitive impairment.
2.2. Diagnosis of Mood Disorder. The diagnosis of current or
past 6-month mood disorder was subsequently performed
by a consultant psychiatrist of the Bologna Psychiatric
Consultation-liaison Service.Thepsychiatrist followedDSM-
IV criteria to formulate the diagnosis of mood disorder and
was blind from results of MDQ and HCL-32.
Patients referred by the Primary Care Group Porto
also received the Patient Health Questionnaire (PHQ-9),
a validated tool, composed by 9 item, corresponding toDSM-
IV diagnostic criteria for major depressive episode [31]. The
score is from 0 to 3 for each question; thus, the total score
can range from 0 to 27. A higher score indicates greater
depression: a patient score of 10 or greater suggests a diagnosis
of MDD.
2.3. Bipolar Spectrum Symptoms Evaluation. Patients with
a current or past (precedent 6 month) diagnosis of major
depressive episode were asked to complete the MDQ and
the HCL-32 to assess the prevalence of symptoms of the
bipolar spectrum. Italian versions of the two instruments are
available after studies of validation conducted in psychiatric
outpatient services [14, 25, 32].
The MDQ is a self-report questionnaire composed by 17
questions: 13 yes/no items on the symptoms derived from
the Diagnostic and Statistical Manual of Mental Disorder
(DSM-IV) criteria and 4 questions about the cooccurrence
of symptoms, levels of functioning, familiar history of BD,
and previous diagnosis of BD. A positive MDQ screen is
defined as endorsement of at least 7 or more symptoms
items, cooccurrence of two ormore symptoms, andmoderate
or severe impairment (MDQ standard cut-off) [13]. We
also used another cut-off of 6 items without criteria of
cooccurrence and functioning, as suggested by Hardoy et al.
in the validation of the ItalianMDQ for single-step studies in
psychiatric outpatients [32].
The HCL-32 consists of 32 yes/no statements regarding
a period when the patient remembers he was in a “high”
mood. Items ask whether specific behaviours (e.g., “I spend
more money/too much money”), thoughts (e.g., “I think
faster”), or emotions (e.g., “my mood is significantly better”)
were present in such a state. Higher scores reflect more
severe hypomanic states. The HCL-32 standard cut-off is
represented by the endorsement of at least 14 items or more.
We also analyzed the cut-off of 12, proposed by Carta for
single-step researches in an outpatient population [25].
In addition, data about sociodemographics, medical his-
tory, family history of psychiatric disorders, and current and
past psychotropic medication were collected using specific
forms.
2.4. Statistical Analyses. Patients screened as positivewith the
considered instruments were compared with those screened
as negative. Chi-square test (𝜒2) was used to compare the
frequency of categorical variables between groups: frequency
of positive and negative screenings and sociodemographic
and clinical features. T-test was used to compare the means
of continuous variables between two or more groups. Cor-
relations between ordered variables as PHQ-9, HCL-32, and
MDQ total score were assessed with Pearson linear corre-
lation (𝜌). The accuracy of the two screening instruments
was calculated in terms of sensitivity and specificity for each
possible cut-off point of the scales, considering as cut-off
only the number of positive answers, in particular for MDQ
no adjunctive criteria were comprised. Performance of the
scales was assessed by means of the Receiver Operating
Characteristic (ROC) Analysis [33]. Data were analyzed by
using SPSS for Windows, version 17.0.
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∗Standard cut-off: endorsement of at least 7 or more symptoms items,
cooccurrence of twoormore symptoms, andmoderate or severe impairment.
MDQ: mood disorder questionnaire; BD: bipolar disorder.





∗Standard cut-off: endorsement of at least 14 or more items.
HCL-32: hypomania checklist; BD: bipolar disorder.
3. Results
3.1. Sociodemographic and Clinic Characteristics. Out of the
94 primary care attenders enrolled in the study, 93 com-
pleted the two questionnaires, and 67 received the diagnostic
assessment of the consultant psychiatrist. The mean age of
the participants was 49.1 (±15.1) years. The majority was
female (72.3%) and had a secondary education level or higher
(64.0%); forty-five point two percent were in a nonprofes-
sional condition and in particular retired (18.0%), housewives
(10.6%), unemployed (4.44%), and students (4.2%). Twenty
point two percent of the sample was separated or divorced.
Eleven patients met criteria for BD II (11.7%). As many as
29 participants had a concomitant anxiety disorder (30.9%):
17 met criteria for generalized anxiety disorder (18.1%) and
12 for panic disorder (12,8%). Smoking habit was present
in 30.0% of the sample, hypertension in 26.6%. Twelve
patients (12.8%) reported the concomitance of two cardio-
vascular risk factors (we consider smoking habit, hyperten-
sion, dyslipidemia, obesity, and diabetes). About two-thirds
of the patients were treated by PCPs with antidepressant
drugs (67.0%); out of these, 74.2% were represented by
Selective Serotonin Reuptake Inhibitors, 16.1% by Serotonin
and Noradrenalin Reuptake Inhibitors, and 9.7% by other
antidepressants including tricyclics.
3.2. Diagnosis of BD and Screening Tests Scores. Patients
meeting criteria for BD had a mean MDQ score of 6.18
(±1.85) and HCL-36 score of 15.36 (±4.90). Patients without
diagnosis of BD had 3.10 (±2.77; 𝑃 < .001) and 11.46 (±6.64;
𝑃 = .069), respectively. Seven patients met criteria with a
clinical diagnosis of BD and screened positive to both the
two screening instruments, using standard cut-off.TheMDQ
positive and HCL-32 positive patients with confirmed or
excluded BD diagnosis are summarized in Tables 1 and 2.
3.3. Symptoms Prevalence. Tables 3 and 4 summarize the
endorsement rate of MDQ and HCL-32 items. In the sample
affirmative responses to MDQ items ranged from 9.7%
(“spending money got you or your family into trouble”)
to 50.5% (“had much more energy than usual”); HCL-
32 affirmative items responses ranged from 7.5% (“drink
more alcohol” and “take more drugs”) to 76.3% (“feel more
energetic and more active”). The symptoms elicited by 8 of
the 13 items of the MDQ and 25 of the 32 items of the
HCL-32 were more prevalent among participants screening
positive than among those screening negative (𝑃 < .05).
The proportion of participants whomet theMDQ diagnostic
criteria for bipolar spectrum was 8.6% for the standard cut-
off and 23.7% considering the less restrictive cut-off of 6. The
percentage of positive screening for history of hypomanic
symptoms at the HCL-32 was 43.0% with 14 as cut-off and
55.9% for 12 or more items endorsed.
3.4. Characteristics Associated with MDQ+ and HCL-32+.
The population identified by MDQ was part of the popu-
lation that screened positive at the HCL-32. Characteristics
associated to positivity to the two tests are presented in
Tables 5 and 6. Using the cut-off standard of MDQ, we find
clinical features related to positive screening: panic disorder
(𝑃 = .029) and smoking habit (𝑃 = .028). MDQ-positive
patients are more likely to be smokers and accordingly had
a higher cardiovascular risk. The less restrictive cut-off (6)
did not find correlations, except for current AD therapy. The
HCL-32 positive patients were younger, more likely to have
a high level of instruction, and they are more likely smokers
(𝑃 < .05).There was no difference in gender between groups.
With the standard cut-off (14), there was also a trend toward
a higher incidence of positive screening in patients who
were separated or divorced, but this did not reach statistical
significance (𝑃 = .06).
3.5. Sensitivity and Specificity. Performances of MDQ and
HCL-32 are illustrated by ROC analysis (Figure 1), with the
report of sensitivity and specificity for each cut-off. The best
accuracy of the test is given by cut-off 5 for MDQ (sensitivity
= .91; specificity = .67) and 15 for HCL-32 (sensitivity = .64;
specificity = .57).
3.6. Relationship with PHQ-9. Analysis conducted in a
subsample (𝑛 = 40) who received the PHQ-9 showed that
higher PHQ-9 score correlated with both higher MDQ and
HCL-32 scores (𝜌 = .316 − 𝑃 = .036; 𝜌 = .530 − 𝑃 < .001,
resp.).
4. Discussion
In this study, we assessed the prevalence of symptoms
ascribable to the spectrum of bipolar disorders through the
use of two instruments meant for the screening of bipolar
disorder (MDQ and HCL-32) in a clinical sample of primary
care depressed patients. The two autosomministrated tests
highlight the pattern of symptoms that can suggest an
undiagnosed BD, but without diagnostic properties. Eleven
patients (11,7%) met diagnostic criteria for BD, all of them
are described as type II bipolar disorder, while the prevalence
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Table 3: Frequencies of endorsed items to MDQ (standard cut-off∗) and correlation with positive screening.
Item MDQ
endorsed,
% Positive, % Negative, %
Chi-sq df 𝑃
(1) You felt so good/hyper that other people thought you were not your
normal self or you were so hyper that you got in trouble? 16.1 37.5 14.1 2.955 1 ns
(2) You were so irritable that you shouted at people or started fights or
arguments? 30.1 62.5 27.1 4.365 1 .037
(3) You felt much more self-confident than usual? 43.0 100.0 37.6 11.598 1 <.001
(4) You got much less sleep than usual and found you did not really miss
it? 29.0 87.5 23.5 14.523 1 <.001
(5) You were much more talkative or spoke much faster than usual? 23.7 75.0 18.8 12.777 1 <.001
(6) Thoughts raced through your head or you could not slow your mind
down? 29.0 75.0 24.7 8.977 1 .003
(7) You were so easily distracted by things around you that you had
trouble concentrating or staying on track? 38.7 75.0 35.3 4.859 1 .028
(8) You had much more energy than usual? 50.5 75.0 48.2 2.095 1 ns
(9) You were much more active or did many more things than usual? 48.4 87.5 44.7 5.362 1 .021
(10) You were much more social or outgoing than usual; for example,
you telephoned friends in the middle of the night? 12.9 12.5 12.9 0.001 1 ns
(11) You were much more interested in sex than usual? 22.6 75.0 17.6 13.758 1 <.001
(12) You did things that were unusual for you or that other people might
have thought were excessive, foolish, or risky? 11.8 25.0 10.6 1.456 1 ns
(13) Spending money got you or your family into trouble? 9.7 12.5 9.4 0.080 1 ns
∗Standard cut-off: endorsement of at least 7 or more symptoms items, cooccurrence of two or more symptoms and moderate or severe impairment.
MDQ: mood disorder questionnaire; Chi-sq: chi-square test; df: degrees of freedom; ns: nonsignificant.
of bipolar spectrum disorder symptoms was very different
between the two instruments. When standard criteria to
establish the test positivity were considered, MDQ was
positive in the 8.6% of the sample, whereas HCL-32 in the
43.0%.
Few studies were conducted in the primary care setting,
and our MDQ positive rate appears to be consistent with
values reported in previous researches recruiting not specific
populations [18, 19]. On the contrary, primary care studies
on selected patients (mood or other psychiatric disorder
and/or in treatment with antidepressant drugs) reported
higher values, between 21.0 and 27.9% [20–22], similar to
those found in studies on psychiatric outpatients services
[34, 35]. The lower prevalence of MDQ-positive reported in
our sample may be due to the inclusion of patients with mild
or subthreshold depressive symptoms, frequently observed in
primary care.
A higher rate of positive screening was found with the
HCL-32. We can compare this result with only one primary
care study using the HCL-32 in a population of patients
with major depressive disorder. However, this research used
a more restrictive cut-off (18) and reported 28.3% of test
positivity [24]. Our finding seems to be more comparable to
those obtained in secondary care and in very selected samples
[27, 36, 37].
Considering the patients identified by the instruments,
we found that MDQ positive patients were all included in the
HCL-32 positive cases. HCL-32 test positivity identified some
specific sociodemographic and clinical features: a younger
age, a higher education level, and smoking habit. Consistently
with previous studies [18, 34, 38], MDQ test positivity was
associated only with clinical characteristics including panic
disorder and smoking habit; in literature, these characteristics
are both strongly related to BD [39, 40]. In addition, we found
an association with MDQ-positive patients with at least two
cardiovascular risk factors. These described correlations did
not reach statistical significance using a less restrictive cut-
off of the MDQ (6). Our data collected in primary care
seem to indicate that MDQ test positivity detects a more
specific population of depressed patients inside a wider group
identified by HCL-32.
The comparison in terms of psychometric proprieties
seems to indicate a better accuracy of MDQ. We can also
compare our findings with those obtained in one another
Italian study that evaluated the two tests in a psychiatric
setting [25]. Our results show lower values of sensitivity and
specificity for both scales; however, MDQ sensitivity and
specificity of the best performing cut-off remain similar to the
results presented by Carta, while accuracy of HCL-32 is lower
to a great extent. In particular, a less restrictive cut-off (5) of
the MDQ showed better accuracy than the cut-off standard.
The same trend of differences between MDQ and HCL-32
remains if we consider the other studies on the accuracy of
the two instruments available in primary care [20, 24].
Considering these data, the rate of MDQ positive seems
to be more consistent with the literature and with data
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Table 4: Frequencies of endorsed items to HCL-32 (standard cut-off∗) and correlation with positive screening.
Item HCL
endorsed,
% Positive, % Negative, %
Chi-sq df 𝑃
(1) I need less sleep 45.2 28.3 67.5 14.143 1 <.001
(2) I feel more energetic and more active 76.3 64.2 92.5 10.144 1 .001
(3) I am more self-confident 67.7 50.9 90.0 15.913 1 <.001
(4) I enjoy my work more 41.9 34.0 52.5 3.217 1 ns
(5) I am more sociable (make more phone calls, go out more) 58.1 41.5 80.0 13.870 1 <.001
(6) I want to travel and/or do travel more 37.6 24.5 55.0 9.018 1 .003
(7) I tend to drive faster or take more risks when driving 12.9 5.70 22.5 5.752 1 .016
(8) I spend more money/too much money 19.4 9.40 32.5 7.770 1 .005
(9) I take more risks in my daily life 19.4 15.1 25.0 1.433 1 ns
(10) I am physically more active (sport, etc.) 59.1 41.5 82.5 15.850 1 <.001
(11) I plan more activities or projects 59.1 35.8 90.0 27.662 1 <.001
(12) I have more ideas, I am more creative 55.9 30.2 90.0 33.083 1 <.001
(13) I am less shy or inhibited 35.5 15.1 62.5 22.378 1 <.001
(14) I wear more colourful and more extravagant clothes/make-up 18.3 3.8 37.5 17.358 1 <.001
(15) I want to meet or actually do meet more people 62.4 37.7 95.0 31.848 1 <.001
(16) I am more interested in sex, and/or have increased sexual desire 38.7 17.0 67.5 24.522 1 <.001
(17) I am more flirtatious and/or am more sexually active 28.0 9.4 52.5 20.991 1 <.001
(18) I talk more 38.7 18.9 72.5 20.448 1 <.001
(19) I think faster 41.9 18.9 27.5 26.928 1 <.001
(20) I make more jokes or puns when I am talking 36.6 22.6 55.0 10.291 1 .001
(21) I am more easily distracted 22.6 18.9 27.5 0.972 1 ns
(22) I engage in lots of new things 28.0 13.2 27.5 13.310 1 <.001
(23) My thoughts jump from topic to topic 24.7 13.2 40.0 8.791 1 .003
(24) I do things more quickly and/or more easily 57.0 35.8 85.0 22.467 1 <.001
(25) I am more impatient and/or get irritable more easily 30.1 18.9 45.0 7.398 1 .007
(26) I can be exhausting or irritating for others 20.4 13.2 30.0 3.954 1 .047
(27) I get into more quarrels 19.4 15.1 25.0 1.433 1 ns
(28) My mood is higher, more optimistic 68.8 52.8 90.0 14.676 1 <.001
(29) I drink more coffee 19.4 13.2 27.5 2.983 1 ns
(30) I smoke more cigarettes 15.1 5.7 27.5 8.503 1 .004
(31) I drink more alcohol 7.5 1.9 15.0 5.632 1 .018
(32) I take more drugs (sedatives, anxiolytics, stimulants) 7.5 5.7 10.0 0.617 1 ns
∗Standard cut-off: endorsement of at least 14 or more items.
List of abbreviations: HCL-32: hypomania checklist; Chi-sq: chi-square test; df: degrees of freedom; ns: nonsignificant.
on the prevalence of BD in depressed patients of primary
care [11]. On the contrary, HCL-32 appears to be more
sensitive in detecting subthreshold hypomanic conditions,
identifying more than one-third of patients as cases, but this
characteristic might not be compatible with the purpose in
primary care of a close examination of all patients that screen
positive. The population identified by MDQ and psychome-
tric proprieties of the scale suggests higher accuracy of the
instrument compared to HCL-32. Besides, MDQ shows a
good feasibility: it is shorter compared toHCL-32 and a lower
cut-off simplifies the scoring even further. These proprieties
make MDQ accessible and usable in a primary care service
andmight aid PCP in order to better recognize BD in patients
presenting depressive symptoms.
An interesting finding emerged from the present study in
a subsample. Patients who reported more hypomanic symp-
toms with a higher total score of the screening instruments
correlated with higher total score for current depressive
symptoms evaluated with the PHQ-9. We hypothesized that
this result, reported also by Smith et al. [24], might be due to a
subjective overestimation of previouswell-being compared to
the current depressive state, but it could also reflect the more
severe condition of bipolar than unipolar depression [41]. As
PHQ-9 is widespread in primary care, we could hypothesize
6 Psychiatry Journal
Table 5: Demographic and clinical characteristics according to threshold score on the MDQ.





Gender, women, % 62.5 72.9 .402, 1 ns 63.6 74.6 1.022, 1 ns
Age, years: mean ± sd 48.4 ± 11.8 49.1 ± 15.4 .018, 1 ns 45.5 ± 13.9 50.2 ± 15.3 1.608, 1 ns
Education level, high, % 62.5 65.1 .833, 1 ns 77.3 60.9 2.019, 1 ns
Civil status, separated/divorced, % 25.0 20.0 .461, 2 ns 31.8 16.9 2.326, 2 ns
Occupation, nonprofessional condition, % 37.5 46.4 .247, 1 ns 40.9 47.1 .276, 1 ns
Current therapy, AD, % 62.5 67.1 .074, 1 ns 45.5 73.2 5.87, 2 .015
Panic attack disorder, % 37.5 10.6 4.757, 1 .029 18.2 11.3 .723, 1 ns
Smoking habit, yes, % 62.5 25.9 4.859, 1 .028 42.9 25 2.459, 1 ns
Cardiovascular risk factors, 2 or more, % 37.5 10.6 4.757, 1 .029 22.7 9.9 2.499, 1 ns
∗Standard cut-off: endorsement of at least 7 or more symptoms items, cooccurrence of two or more symptoms, and moderate or severe impairment.
∗∗Cut-off 6: endorsement of at least 6 or more symptoms items, with no adjunctive criteria.
List of abbreviations: MDQ: mood disorder questionnaire; Chi-sq: chi-square test; df: degrees of freedom; sd: standard deviation; ns: nonsignificant; AD:
antidepressant.
Table 6: Demographic and clinical characteristics according to threshold score on the HCL-32.
HCL-32: Standard cut-off∗ HCL-32: cut-off 12∗∗
Positive Negative 𝐹/chi-Square,df 𝑃 Positive Negative
𝐹/chi-Square,
df 𝑃
Gender, women % 72.5 71.7 .011, 1 ns 71.2 73.2 .051, 1 ns
Age, years: mean ± sd 45.7 ± 13.6 51.6 ± 15.6 3.457, 1 ns 46.0 ± 14.2 52.9 ± 15.3 4.92, 1 .029
Education level, high % 76.9 55.8 5.273, 1 .037 78.4 47.5 9.34, 1 .002
Civil Status, separated/divorced % 30.0 13.2 5.638, 2 ns 25.0 14.6 2.124, 2 ns
Occupation, non professional condition % 42.5 48.1 .301, 1 ns 42.3 50.0 .560, 1 ns
Current therapy, AD % 57.5 73.6 2.674, 1 ns 44.2 19.5 6.343, 1 .012
Panic attack disorder % 12.5 13.2 .012, 1 ns 13.5 12.2 .035, 1 ns
Smoking habit, yes % 42.1 19.6 5.273, 1 .022 38.8 17.5 4.83, 1 .028
Cardiovascular risk factors, 2 or more % 20.0 7.5 3.176, 1 ns 15.4 9.8 .654, 1 ns
∗Standard cut-off: endorsement of at least 14 or more items.
∗∗Cut-off 12: endorsement of at least 12 or more items.
List of abbreviations: HCL-32: hypomania checklist; Chi-sq: chi-square test; df: degrees of freedom; sd: standard deviation; ns: non significant; AD:
antidepressant.
a two-stage strategy to refine the mood disorders assessment.
In particular, PCPs should also administer MDQ to patients
reporting high PHQ-9 score.
4.1. Limitations. The present study has several limitations.
The initial assessment of mood disorder was done by PCPs,
and there is the possibility of a misdiagnosis of depression.
Subsequently the diagnosis of mood disorder was performed
by a consultant psychiatrist following DSM-IV criteria, but
without a structured diagnostic interview like the Structured
Clinical Interview for DSM-IV Axis I Disorders (SCID-I)
[42]. As a consequence, we admit a risk of selection of a highly
heterogeneous sample and a possible under or overestimate
of the diagnosis of BD; however, our symptoms prevalence
and our values of sensitivity and specificity seem in line with
previous literature on this topic [18, 19].
Furthermore, the sample was relatively small, and we
gathered data to perform ROC analysis only for 67 patients;
therefore, our results need to be interpreted with caution and
further researches including studies with higher sample sizes
are needed.
Finally, we did not collect data about excluded patients
and those that refused participation in the study or psychi-
atric consultation; however, the recruitment was performed
in the busy setting of the primary care, and we chose to adopt
a simple and easy procedure to avoid a supplementary work
for PCPs.
5. Conclusion
PCP is often the first health contact for assessment and
treatment of patients with depressive symptoms. Despite
programs of training and collaboration aimed to increase
the PCP’s ability to detect depressive disorders, differential

















MDQ       1 2 3 4 5 6 7 8 9 10 11 12 13
Sensitivity 1.00 1.00 1.00 .91 .91 .55 .36 .27 .09 .09 .00 .00 .00
Specificity .20 .37 .46 .54 .67 .81 .87 .93 .96 .98 .98 1.00 1.00
.80 .63 .54 .46 .33 .19 .13 .07 .04 .02 .02 .00 .00
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Sensitivity 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 .91 .82 .73 .64 .64 .64 .55
Specificity .02 .09 .13 .15 .20 .20 .22 .26 .30 .33 .37 .43 .48 .54 .57 .63
.98 .91 .87 .85 .80 .80 .78 .74 .70 .67 .63 .57 .52 .46 .43 .37
17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32
Sensitivity .27 .18 .18 .18 .18 .18 .09 .09 .09 .00 .00 .00 .00 .00 .00 .00
Specificity .76 .80 .87 .89 .93 .96 .98 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00









Figure 1: ROC Analysis of the performance of MDQ and HCL-32 in the sample.
complex task. This background supports the use of specific
instruments that can raise diagnostic accuracy of PCPs.
In the present study, MDQ showed acceptable proprieties
as screening instrument, with better psychometric character-
istics using 5 as cut-off. MDQ appears to be more specific,
easier and shorter than HCL-32, and it also takes little
time to score. These features fit well in the busy setting of
primary care, where PCPs have little time to dedicate to
assessment. It cannot solve the diagnostic doubt between
unipolar and bipolar depression, but it is the chance of having
more patient’s information during the visit to make correct
therapeutic choices or to proceed in further investigations or
refer to mental health services.
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